Skip to main content
04_News Effland
© Alessandro Winkler / UKB

News categories: Honors & Funding

Women TechEU Start-Up Funding for University of Bonn Spin-Off

SmartContrast reduces use of contrast agents

relios.vision GmbH, a University of Bonn start-up that has developed the SmartContrast software, receives funding from the European Innovation Council’s (EIC) Women TechEU program. ImmunoSensation² member Prof. Alexander Effland, together with experts from the fields of medicine and mathematics is involved in the company. Using artificial intelligence, SmartContrast aims to lower the use of contrast agents for magnetic resonance imaging of the brain, thus reducing examination costs and potential risks for patients and the environment.

The program aims to support deep tech start-ups led in part by women, as currently only about 15 percent of all start-ups are counting women among their founding members. Even today in the EU only about five percent of risk capital goes to mixed-gender founding teams, while the figure for women-only founding teams (a mere two percent) is even lower. Start-up companies dedicated to innovative technologies are facing an even bigger gender gap.

“We’re very pleased about the funding that enables us to proceed with the next steps in the medicinal product development of our SmartContrast software,” states Dr. Katerina Deike-Hofmann, relios.vision GmbH co-founder and managing partner and also physician at the University Hospital Bonn’s Neuroradiology Clinic.

ImmunoSensation2 member Prof. Alexander Effland from the Institute for Applied Mathematics at the University of Bonn, also forming part of the SmartContrast team, comments: “The interdisciplinary cooperation has been a very beneficial experience for everyone involved. I’m glad that our mathematical research helps hospitals on the path to becoming more sustainable and reducing the impact on the environment.”

Prof. Alexander Radbruch, Director of the Neuroradiology Clinic at the University Hospital Bonn, stresses the great innovation potential science start-ups carry: “relios.vision GmbH serves as a very good example for research leading to the creation of real products and benefitting our patients.”

Selected start-ups receive grants of €75,000 as well as mentoring, coaching and access to an EU-wide network of entrepreneurs. All companies are characterized by their strong power to innovate, excellent results both in research and in development, their impact in the EU and a strong female representation on managing boards or founding teams. Among the successful applicants were a total of 134 companies stemming from 26 EU countries and 16 industry sectors, 18 of which came from Germany.

Supporting women at the University of Bonn not only plays a key role with regards to research but also when it comes to starting a company. The enaCom Transfer Center bundles specific support for female entrepreneurs. Further information is available on the enaCom web page.

Related news

Reckzeh News

News categories: Honors & Funding

Creating Personalized Cancer Treatments

Bonn researchers aim to improve colon cancer treatment using 3D organoids and digital twins. Funded by the Federal Ministry of Education and Research (BMBF), a collaborative project involving the University of Bonn, the company ESQlabs and the University Hospital Bonn is seeking to refine the therapy recommendations given to colon cancer patients. To this end, “ISPOT-K” is merging organoids taken from patients with the power of digital twin technology.
View entry
Prof. Dr. Valentin Schäfer

News categories: Honors & Funding

Valentin Schäfer appointed to Specialized Ethics Committee

Prof. Valentin S. Schäfer, Head of the Section of Rheumatology at the University Hospital Bonn (UKB) and researcher at the University of Bonn, has been appointed to the newly created Specialized Ethics Committee for Special Procedures by State Secretary Dr. Thomas Steffen at the Federal Ministry of Health. The committee, which is based at the Federal Institute for Drugs and Medical Devices (BfArM), will begin its work on July 1, 2025 and is responsible for the ethical evaluation of complex clinical trials.
View entry
Honorary Doctorate Sharon Lewin

News categories: Honors & Funding

Honorary Doctorate awarded to Sharon Lewin

The Faculty of Medicine at the University of Bonn has conferred an honorary doctorate on the illustrious researcher Professor Sharon Lewin. The Director of the Peter Doherty Institute for Infection and Immunity and the Cumming Global Centre for Pandemic Therapeutics, Professor Lewin is also a Laureate Professor of Medicine at the University of Melbourne in Australia and collaborates with the University Hospital Bonn. She is being recognized for her exceptional research on the international stage and her groundbreaking work in the field of HIV research in particular.
View entry

Back to the news overview